{"id":5450,"date":"2025-01-31T11:48:17","date_gmt":"2025-01-31T10:48:17","guid":{"rendered":"https:\/\/cnatm-1.betapage.de\/?p=5450"},"modified":"2025-01-31T11:49:13","modified_gmt":"2025-01-31T10:49:13","slug":"cnatm-lecture-patrick-baumhof","status":"publish","type":"post","link":"https:\/\/cnatm.de\/en\/cnatm-lecture-patrick-baumhof\/","title":{"rendered":"CNATM Lecture: Patrick Baumhof"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5450\" class=\"elementor elementor-5450\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6363f8b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6363f8b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-807a88d\" data-id=\"807a88d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0b60e27 elementor-widget elementor-widget-heading\" data-id=\"0b60e27\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">CNATM Lecture: Patrick Baumhof<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-872b54b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"872b54b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-3c861fc\" data-id=\"3c861fc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-39a4d74 elementor-widget elementor-widget-text-editor\" data-id=\"39a4d74\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h4><strong>23. January 2024, 5:15 pm<br \/><\/strong><\/h4><p><strong>Developing mRNA based Therapeutics<br \/><\/strong>Over the past years mRNA based therapeutics moved into the focus of drug development. With mRNA based vaccines in the market now the field is looking towards broader application of the technology. As a pioneer in the field CureVac has discovered several main principles that are relevant in development. The presentation discusses different applications of mRNA in drug development.<\/p><p><b>Patrick Baumhof<\/b> is Senior Vice President of Technology at CureVac (T\u00fcbingen)<\/p><p>Location: ICEM \/ House L, Seminarraum, W\u00fcrmtalstr. 201, 81377 Munich<\/p><p><strong>Registration by e-mail is required for participation<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-f715f57\" data-id=\"f715f57\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-011328a elementor-widget elementor-widget-image\" data-id=\"011328a\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"904\" height=\"1280\" src=\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg\" class=\"attachment-full size-full wp-image-3251\" alt=\"CNATM Lecture: Patrick Baumhof\" srcset=\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg 904w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt-212x300.jpg 212w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt-723x1024.jpg 723w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt-768x1087.jpg 768w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt-8x12.jpg 8w\" sizes=\"(max-width: 904px) 100vw, 904px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-39021d3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"39021d3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-5e78ff6\" data-id=\"5e78ff6\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-20cae97 elementor-widget elementor-widget-spacer\" data-id=\"20cae97\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>CNATM Lecture: Patrick Baumhof 23. Januar 2024, 17:15 Uhr Developing mRNA based TherapeuticsIn den letzten Jahren sind mRNA-basierte Therapeutika in den Mittelpunkt der Arzneimittelentwicklung ger\u00fcckt. Jetzt, da mRNA-basierte Impfstoffe auf dem Markt sind, richtet sich das Augenmerk auf eine breitere Anwendung der Technologie. Als Pionier auf diesem Gebiet hat CureVac mehrere Hauptprinzipien entdeckt, die f\u00fcr [&hellip;]<\/p>","protected":false},"author":11,"featured_media":3251,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[64],"tags":[],"class_list":["post-5450","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>CNATM Lecture: Patrick Baumhof - CNATM<\/title>\n<meta name=\"description\" content=\"Developing mRNA based TherapeuticsIn den letzten Jahren sind mRNA-basierte Therapeutika in den Mittelpunkt der Arzneimittelentwicklung ger\u00fcckt. Jetzt, da mRNA-basierte Impfstoffe auf dem Markt sind, richtet sich das Augenmerk auf eine breitere Anwendung der Technologie. Als Pionier auf diesem Gebiet hat CureVac mehrere Hauptprinzipien entdeckt, die f\u00fcr die Entwicklung relevant sind. In der Pr\u00e4sentation werden verschiedene Anwendungen von mRNA in der Arzneimittelentwicklung er\u00f6rtert.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cnatm.de\/en\/cnatm-lecture-patrick-baumhof\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CNATM Lecture: Patrick Baumhof - CNATM\" \/>\n<meta property=\"og:description\" content=\"Developing mRNA based TherapeuticsIn den letzten Jahren sind mRNA-basierte Therapeutika in den Mittelpunkt der Arzneimittelentwicklung ger\u00fcckt. Jetzt, da mRNA-basierte Impfstoffe auf dem Markt sind, richtet sich das Augenmerk auf eine breitere Anwendung der Technologie. Als Pionier auf diesem Gebiet hat CureVac mehrere Hauptprinzipien entdeckt, die f\u00fcr die Entwicklung relevant sind. In der Pr\u00e4sentation werden verschiedene Anwendungen von mRNA in der Arzneimittelentwicklung er\u00f6rtert.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cnatm.de\/en\/cnatm-lecture-patrick-baumhof\/\" \/>\n<meta property=\"og:site_name\" content=\"CNATM\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-31T10:48:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-31T10:49:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"904\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Patrizia Torelli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrizia Torelli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/\"},\"author\":{\"name\":\"Patrizia Torelli\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\"},\"headline\":\"CNATM Lecture: Patrick Baumhof\",\"datePublished\":\"2025-01-31T10:48:17+00:00\",\"dateModified\":\"2025-01-31T10:49:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/\"},\"wordCount\":107,\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg\",\"articleSection\":[\"Event\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/\",\"url\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/\",\"name\":\"CNATM Lecture: Patrick Baumhof - CNATM\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg\",\"datePublished\":\"2025-01-31T10:48:17+00:00\",\"dateModified\":\"2025-01-31T10:49:13+00:00\",\"description\":\"Developing mRNA based TherapeuticsIn den letzten Jahren sind mRNA-basierte Therapeutika in den Mittelpunkt der Arzneimittelentwicklung ger\u00fcckt. Jetzt, da mRNA-basierte Impfstoffe auf dem Markt sind, richtet sich das Augenmerk auf eine breitere Anwendung der Technologie. Als Pionier auf diesem Gebiet hat CureVac mehrere Hauptprinzipien entdeckt, die f\u00fcr die Entwicklung relevant sind. In der Pr\u00e4sentation werden verschiedene Anwendungen von mRNA in der Arzneimittelentwicklung er\u00f6rtert.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg\",\"width\":904,\"height\":1280,\"caption\":\"CNATM Lecture: Patrick Baumhof\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cnatm.de\/#website\",\"url\":\"https:\/\/cnatm.de\/\",\"name\":\"CNATM\",\"description\":\"Cluster for Nucleic Acid Therapeutics Munich\",\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cnatm.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cnatm.de\/#organization\",\"name\":\"CNATM\",\"url\":\"https:\/\/cnatm.de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"width\":2362,\"height\":479,\"caption\":\"CNATM\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\",\"name\":\"Patrizia Torelli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"caption\":\"Patrizia Torelli\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CNATM Lecture: Patrick Baumhof - CNATM","description":"Developing mRNA based TherapeuticsIn den letzten Jahren sind mRNA-basierte Therapeutika in den Mittelpunkt der Arzneimittelentwicklung ger\u00fcckt. Jetzt, da mRNA-basierte Impfstoffe auf dem Markt sind, richtet sich das Augenmerk auf eine breitere Anwendung der Technologie. Als Pionier auf diesem Gebiet hat CureVac mehrere Hauptprinzipien entdeckt, die f\u00fcr die Entwicklung relevant sind. In der Pr\u00e4sentation werden verschiedene Anwendungen von mRNA in der Arzneimittelentwicklung er\u00f6rtert.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cnatm.de\/en\/cnatm-lecture-patrick-baumhof\/","og_locale":"en_US","og_type":"article","og_title":"CNATM Lecture: Patrick Baumhof - CNATM","og_description":"Developing mRNA based TherapeuticsIn den letzten Jahren sind mRNA-basierte Therapeutika in den Mittelpunkt der Arzneimittelentwicklung ger\u00fcckt. Jetzt, da mRNA-basierte Impfstoffe auf dem Markt sind, richtet sich das Augenmerk auf eine breitere Anwendung der Technologie. Als Pionier auf diesem Gebiet hat CureVac mehrere Hauptprinzipien entdeckt, die f\u00fcr die Entwicklung relevant sind. In der Pr\u00e4sentation werden verschiedene Anwendungen von mRNA in der Arzneimittelentwicklung er\u00f6rtert.","og_url":"https:\/\/cnatm.de\/en\/cnatm-lecture-patrick-baumhof\/","og_site_name":"CNATM","article_published_time":"2025-01-31T10:48:17+00:00","article_modified_time":"2025-01-31T10:49:13+00:00","og_image":[{"width":904,"height":1280,"url":"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg","type":"image\/jpeg"}],"author":"Patrizia Torelli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Patrizia Torelli","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#article","isPartOf":{"@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/"},"author":{"name":"Patrizia Torelli","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e"},"headline":"CNATM Lecture: Patrick Baumhof","datePublished":"2025-01-31T10:48:17+00:00","dateModified":"2025-01-31T10:49:13+00:00","mainEntityOfPage":{"@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/"},"wordCount":107,"publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"image":{"@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg","articleSection":["Event"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/","url":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/","name":"CNATM Lecture: Patrick Baumhof - CNATM","isPartOf":{"@id":"https:\/\/cnatm.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage"},"image":{"@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg","datePublished":"2025-01-31T10:48:17+00:00","dateModified":"2025-01-31T10:49:13+00:00","description":"Developing mRNA based TherapeuticsIn den letzten Jahren sind mRNA-basierte Therapeutika in den Mittelpunkt der Arzneimittelentwicklung ger\u00fcckt. Jetzt, da mRNA-basierte Impfstoffe auf dem Markt sind, richtet sich das Augenmerk auf eine breitere Anwendung der Technologie. Als Pionier auf diesem Gebiet hat CureVac mehrere Hauptprinzipien entdeckt, die f\u00fcr die Entwicklung relevant sind. In der Pr\u00e4sentation werden verschiedene Anwendungen von mRNA in der Arzneimittelentwicklung er\u00f6rtert.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/cnatm-lecture-patrick-baumhof\/#primaryimage","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/01\/Unbenannt.jpg","width":904,"height":1280,"caption":"CNATM Lecture: Patrick Baumhof"},{"@type":"WebSite","@id":"https:\/\/cnatm.de\/#website","url":"https:\/\/cnatm.de\/","name":"CNATM","description":"Cluster for Nucleic Acid Therapeutics Munich","publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cnatm.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cnatm.de\/#organization","name":"CNATM","url":"https:\/\/cnatm.de\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","width":2362,"height":479,"caption":"CNATM"},"image":{"@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e","name":"Patrizia Torelli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","caption":"Patrizia Torelli"}}]}},"_links":{"self":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5450","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/comments?post=5450"}],"version-history":[{"count":4,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5450\/revisions"}],"predecessor-version":[{"id":5454,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5450\/revisions\/5454"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media\/3251"}],"wp:attachment":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media?parent=5450"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/categories?post=5450"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/tags?post=5450"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}